Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

Gastric cancer, also known as stomach cancer, is a type of cancer that starts in the stomach lining. Detecting the disease early can improve outcomes, but current methods are often invasive. A new ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

Bezuclastinib plus sunitinib showed favorable safety and efficacy in GIST, outperforming sunitinib alone in phase 3 Peak ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Walker, 66, transitioned on December 26, 2025, after a two-year battle with stomach cancer (GIST). She was born in Hamilton, Bermuda on October 14, 1958, ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.

[25] In view of these data, imatinib has become the first-line treatment for patients presenting with advanced GIST. Since the 800 mg dose causes more pronounced toxic effects but equivalent ...

When a child develops a brain tumor, early diagnosis is essential. Alan Cohen, M.D., director of pediatric neurosurgery at Johns Hopkins Children’s Center, shares the most common signs and symptoms ...

which contribute to the tumor tissue stromal architecture and to the survival and proliferation of the tumor cells. We will also survey for other targets for PIN1 that might be important in ...